The following post is by HIVMA Executive Director Andrea Weddle, reporting from the International AIDS Conference in Vienna. “There’s no separate science for the rich and poor. The research applies to both,” said Dr. Peter Mugyenyi when asked whether “when to start to HIV treatment” was a real question for Uganda and countries in sub-Saharan […]
Vienna — “Slow, timid, and uncoordinated.” Those were the words Tony Harries, Senior Adviser to the International Union Against Tuberculosis and Lung Disease, used to describe the response to deadly HIV/TB co-infection, with its 40 percent mortality. Harries opened the session of TB and HV Management in High-Prevalence Settings Wednesday morning at the 18th International […]
During a press conference Tuesday at the International AIDS Conference in Vienna, Anthony Fauci, MD, Director of the National Institute of Allergy and Infectious Diseases at NIH, describes the Vaginal and Oral Interventions to Control the Epidemic (VOICE) trial. The study is testing the safety and efficacy of microbicide gel containing the ARV drug tenofovir, […]
HIV
Well into the era of effective treatment for HIV, a question contributed to a lag in access to the life-saving antiretroviral drugs in resource limited countries: […]
Tuberculosis
HYDERABAD, INDIA – The world is one major step closer to a vaccine against tuberculosis, researchers said here, with results from a clinical trial of an […]
Research & Development
While the committee examining the Ebola epidemic in the Democratic Republic of Congo emerged today from its 5th meeting with the conclusion that transmissions of the […]
Policy
A natural death: The political battlefield of infections and migrant children’s bodies – Tracing the events surrounding the death of eight-year-old Felipe Alonso Gomez in U.S. […]